Toxins | |
The Anti-Cancer Potency and Mechanism of a Novel Tumor-Activated Fused Toxin, DLM | |
Dejun Sun1  Miaonan Sun1  Wenhe Zhu2  Zhiding Wang1  Yuefei Li1  Jie Ma3  | |
[1] Department of Biomedicine, Institute for Regeneration Medicine, Jilin University, Changchun 130021, China; E-Mails:;Department of Biochemistry, School of Basic Medicine, Jilin Medical College, Jilin 130000, China; E-Mail:;School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China | |
关键词: tumor-activated; fused toxin; disintegrin; melittin; anti-cancer; | |
DOI : 10.3390/toxins7020423 | |
来源: mdpi | |
【 摘 要 】
Melittin, which acts as a membrane-disrupting lytic peptide, is not only cytotoxic to tumors, but also vital to normal cells. Melittin had low toxicity when coupled with target peptides. Despite significant research development with the fused toxin, a new fused toxin is needed which has a cleavable linker such that the fused toxin can release melittin after protease cleavage on the tumor cell surface. We describe a novel fused toxin, composed of disintegrin, uPA (urokinase-type plasminogen activator)-cleavable linker, and melittin. Disintegrin is a single strand peptide (73 aa) isolated from
【 授权许可】
CC BY
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190016611ZK.pdf | 1360KB | download |